Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
277,950,423
-
Shares change
-
-4,011,547
-
Total reported value, excl. options
-
$3,923,978,054
-
Value change
-
-$60,291,396
-
Put/Call ratio
-
28%
-
Number of buys
-
113
-
Number of sells
-
-111
-
Price
-
$14.12
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q3 2020
282 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q3 2020.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 277,950,423 shares
of 308,713,740 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (25,122,048 shares), VANGUARD GROUP INC (23,187,567 shares), Redmile Group, LLC (23,075,807 shares), BlackRock Inc. (20,968,808 shares), JANUS HENDERSON GROUP PLC (14,106,259 shares), MORGAN STANLEY (11,113,785 shares), Avoro Capital Advisors LLC (10,850,000 shares), STATE STREET CORP (8,929,059 shares), JPMORGAN CHASE & CO (8,300,766 shares), and Palo Alto Investors LP (7,867,114 shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.